## HRL: Hormel Foods Corporation - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 1.0% below STRENGTH zone (4.0-10.0%); PEG 3.39 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.2% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($22.21)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Franklin Resources Inc. Raises Stock Position in Hormel Foods Corporation $HRL**
- Source: MarketBeat | 20251201T090309 | Neutral | Relevance: 99%
- Franklin Resources Inc. substantially increased its holdings in Hormel Foods Corporation by 67.4% in the second quarter, now owning 296,782 shares valued at approximately $8.98 million. Despite this increased institutional interest, Hormel Foods recently missed EPS expectations and has a consensus "Hold" rating from analysts with an average target price of $28.86. The company also announced a quarterly dividend increase to $0.2925 per share, resulting in a 5.0% annualized yield.

**2. Rosen Law Firm Encourages Hormel Foods Corporation Investors to Inquire About Securities Class Action Investigation - HRL**
- Source: Fox 59 | 20251202T175800 | Neutral | Relevance: 99%
-  The Rosen Law Firm is investigating a potential securities class action against Hormel Foods Corporation (NYSE: HRL) after allegations of misleading business information. This investigation follows a Wall Street Journal article on October 29, 2025, detailing Hormel's reduced forecast due to price pressures, bird flu, and a factory fire, which caused a 9.1% stock drop. Investors who purchased Hormel securities may be entitled to compensation.

**3. Hormel Foods Announces 2025 Class of 10 Under 20 Food Heroes**
- Source: Morningstar | 20251201T130000 | Bullish | Relevance: 98%
- Hormel Foods has announced its 2025 class of "10 Under 20 Food Heroes," recognizing ten young individuals from across the United States who are making significant contributions to creating a more transparent, secure, and sustainable food system. These honorees will gather at Hormel Foods' global headquarters for recognition, mentorship, and support to amplify their projects. The program also includes mental health and resilience training for the participants and their families through Be Strong, aiming to bolster their well-being as they address food system challenges.

**4. Rosen Law Firm Encourages Hormel Foods Corporation Investors to Inquire About Securities Class Action Investigation - HRL**
- Source: WOWK 13 News | 20251202T175800 | Neutral | Relevance: 97%
- The Rosen Law Firm is investigating potential securities claims against Hormel Foods Corporation (NYSE: HRL) after The Wall Street Journal reported on October 29, 2025, that Hormel cut its forecast due to price pressures, bird flu, and a fire, also parting ways with its CFO. The firm encourages investors who purchased Hormel securities to inquire about a class action seeking compensation for investor losses. Hormel's stock fell 9.1% on the news of the forecast cut and CFO departure.

**5. These 5 parent companies built big marketing moments around their brands**
- Source: Fast Company | 20251202T120958 | Bullish | Relevance: 86%
- This article highlights five parent companies—Coca-Cola, AB InBev, Haleon, Hormel Foods, and J.Crew Group—that successfully created significant marketing moments across their diverse brand portfolios. These companies leveraged targeted campaigns, collaborations, and innovative strategies to drive engagement and sales for multiple brands, showcasing their ability to connect with business and culture. The piece details specific examples, such as Sprite surpassing Pepsi, Corona's 100th anniversary, and J.Crew's catalog relaunch, underscoring the impact of their multi-brand marketing efforts.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $30 | $31 | -3% |
| 2025-12-05 | Piper Sandler | $26 | $25 | +4% |
| 2025-12-05 | JP Morgan | $28 | $27 | +4% |
| 2025-12-05 | B of A Securiti | $26 | $25 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | main | Overweight |
| 2025-12-05 | Piper Sandler | main | Neutral |
| 2025-12-05 | JP Morgan | main | Overweight |
| 2025-12-05 | B of A Securiti | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 4 ($0.26M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Vanguard Group Inc: 6.8% (+2.0%)
- State Street Corpora: 5.1% (+1.0%)
- Blackrock Inc.: 4.6% (+2.2%)
- Invesco Ltd.: 2.1% (+66.5%)
- Geode Capital Manage: 1.5% (+1.7%)

### Key Risks

1. Valuation risk: PEG 3.4x with declining EPS estimates leaves no margin for error.
2. Long-term trend broken: trading 16.6% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 3 raises (avg +4%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 3.39 signals overvaluation risk, limited margin of safety. Forward P/E 14.7x stretched relative to 7% growth. Balance sheet: strong liquidity (2.5x), low leverage (D/E 0.18). Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.1B |
| Beta | 0.33 |
| 52W Range | $21.03 - $33.80 |
| Short Interest | 5.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.39 |
| Forward P/E | 14.7 |
| Current P/E | 15.7 |
| YoY Growth | 6.9% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 4.2% to 1.0% (-3.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.0pp (needs >4.0% for momentum thesis). MRS_5 (-1.0%) diverging from MRS_20 - short-term weakness emerging. Below SMA200 (0.83x), long-term trend not supportive. RSI neutral at 54.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.00% (CS: 70) | Neutral |
| RSI_14 | 54.1 | Neutral |
| MACD Histogram | 0.18 | Bullish |
| vs SMA20 | 1.028x | Above |
| vs SMA50 | 0.993x | Below |
| vs SMA200 | 0.834x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $23.09
- **Stop Loss:** $22.21 (3.8% risk)
- **Target:** $23.97 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 1136
- **Position Value:** $26,230.24
- **Portfolio %:** 26.23%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-26 (Est: $0.32)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.30 | $0.32 | +6.0% |
| 2025Q3 | $0.41 | $0.35 | -14.5% |
| 2025Q2 | $0.34 | $0.35 | +3.3% |
| 2025Q1 | $0.37 | $0.35 | -6.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*